SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving attention, with traders pointing to leveraged long liquidations and broader risk-off pressure. The community is split between buying an oversold dip near technical support and expecting further declines if selling continues.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial of GPS has reached the 80th event, and the company expects topline results this month, driving intense attention ahead of the AML data readout. Traders celebrated a sharp after-hours move and speculated about a data leak or short covering, while others cautioned that the trial remains blinded and its outcome is unknown.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints from users whose work was interrupted. Traders debated whether the prolonged disruption should pressure the stock, which held near flat-to-positive, while some speculated about a cyberattack without confirmation.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to risk-off sentiment, inflation and rate-hike concerns, and leveraged liquidations. The steep decline has sparked debate over whether support will hold or losses will deepen, while some holders are buying the dip and others cite stalled regulatory progress and weak demand as reasons for caution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure alongside Bitcoins slide and broader weakness in crypto-linked stocks, with traders highlighting fresh lows and arguing over whether the selloff has further to run or the shares are forming a base. Some also point to COINs underperformance versus Bitcoin and concerns about trading activity, while a smaller group sees an oversold bounce opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention amid weakness in Ethereum and broader crypto-linked stocks, with traders focused on its ETH-treasury exposure and the shares decline. The community is split between dip-buyers expecting a recovery and critics questioning Tom Lees strategy, company spending, transparency and buybacks.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Would you take a generic version of Ozempic for weight loss? (Poll)

Health Canada has approved the first generic version of brand-name Ozempic. The department says Canada is the first G7 country to authorize generic semaglutide. The injectable medication is manufactured by Dr. Reddy's Laboratories in India and is approved for the once-weekly treatment of Type 2 diab...

Canada gives nod for Dr Reddy’s semaglutide

Hyderabad: Dr Reddy's Labs said Wednesday that Health Canada has approved its generic semaglutide injection, making it the first company to secure mar.

Sensex Topples 400 Points, Nifty Down 0.41% On IT, Pharma Sell-off

Indian equity markets opened weak on Friday amid persistent geopolitical tensions and the ongoing Q4 earnings season. Sensex fell 400 points to 77,263, while Nifty declined 100 points in early trade. IT, financial, and pharma stocks faced heavy selling pressure, with Cipla, Infosys, Dr Reddy’s, Sun Pharma, TCS, and ICICI Bank as top laggards. FMCG and chemical stocks provided some support.

Brief India: Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums and more

In this briefing: Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Primer: Anthem Biosciences (1234D IN) - Apr 2026 Amagi Media Labs: Taking Media Companies to the Cloud Universe Charting Course: Oil Cognitive Arbitrage and the PetroYuan Debut (4/17/26) Paracetamol’s Supply Crisis: The Tablet Squeezing Indian Pharma Margins 1. Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Sharda Cropchem is an asset-light agrochemical supplier that sources products mainly from China and India, sells globally, and builds competitive advantage through extensive regulatory product registrations instead of manufacturing capabilities. They invest heavily in product registrations, creating large pipeline that converts into revenue over time, driving strong cash flows funding growth internally, and supporting dividends despite high accounting amortization charges. Sharda’s massive registration pipeline and presence in regulated markets drive growth despite sourcing and forex risks.

Brief India: Primer: Anthem Biosciences (1234D IN) - Apr 2026 and more

In this briefing: Primer: Anthem Biosciences (1234D IN) - Apr 2026 Amagi Media Labs: Taking Media Companies to the Cloud Universe Charting Course: Oil Cognitive Arbitrage and the PetroYuan Debut (4/17/26) Paracetamol’s Supply Crisis: The Tablet Squeezing Indian Pharma Margins Gold Loan: How a Collateral-First Product Became India's Largest Retail Loan 1. Primer: Anthem Biosciences (1234D IN) - Apr 2026 Anthem Biosciences is a fully integrated Contract Research, Development, and Manufacturing Organization (CRDMO) providing end-to-end services for small and large molecules to the global pharmaceutical and biotechnology sectors. The company has demonstrated a strong financial track record, with a 32% CAGR in operating revenue between FY23 and FY25, and boasts industry-leading EBITDA margins. Key growth drivers include its leadership in fermentation capacity in India, expertise in advanced therapeutic modalities like ADCs and RNAi, and a strategic focus on backward integration to reduce reliance on external suppliers.

Trading Radar For Oct 23: Ola, BEL, Tata Motors, NMDC, Torrent Pharma, Lloyds Metals, PNB Stocks Are In Focus

Equity

Hindustan Unilever and Colgate Palmolive (India) are among the companies expected to report their Q2 results on Thursday

Will Trump’s 100% Tariffs Derail Indian Pharma Stocks? SEBI Analyst Flags Key Levels For Traders

The new U.S. duty has already triggered a slide in major Asian pharma names, raising concerns about how Indian peers will react in the coming weeks.

India’s Healthcare Index Sinks After Trump’s Pharma Tariff Blow — SEBI Analyst Sees Risks For Gland, Biocon, Dr. Reddy’s

The analyst noted that Syngene, Piramal Pharma, and Zydus Lifesciences may be better positioned, as their contract manufacturing models and biologics portfolios are less susceptible to the tariff impact.

Trading Radar For September 17: Jindal Steel, Vedanta, RailTel, BEL, Amber, Lupin, Stocks Are On Investors’ Watchlist

Urban Company is set to list at 10 am, GMP data indicating nearly a 50% premium over the issue price.

Trading Radar For September 15: Tata Technologies, Vedanta, Railtel, Info Edge, Apollo Hospital Stocks Are On Investors’ Watchlist

Gift Nifty indicates a positive opening for benchmark Indian indices

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment refers to the manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Dr. Reddy`s Laboratories Ltd.

Neutral Sentiment

Indian equity markets are set for a record opening on Thursday, with the Gift Nifty, an early indicator for the Nifty 50 index, edging 325 points higher at 8:40 a.m. IST.&nbsp;&nbsp;The markets&nbsp;reached a one-year high on Monday, led by buying in banks, energy and IT stocks. The benchmark indices ended marginally higher on the special ‘Muhurat Trading’ session on Tuesday, with the Sensex gaining 0.07% and the Nifty climbing 0.10% higher.Asian markets were trading mixed on Thursday. Japan’s Nikkei was the biggest laggard, while the bourses in Shanghai, Shenzhen and Taiwan declined too. The primary index in Thailand was the top gainer.At the time of writing, the gold spot price fell 0.36% to $4,083.05&nbsp;per ounce. Brent crude traded up 2.33% at $64.05&nbsp;per barrel.Stock WatchBharat Electronics: Received a ₹633 crore order from Cochin Shipyard for sensors, weapon systems, and communication equipment, reinforcing its defence order book.Punjab National Bank: PNB has divested 10% of its stake in Canara HSBC Life Insurance, raising ₹1,007 crore by selling 9.5 crore shares at ₹106 each, thereby reducing its holding to 13%.Dr. Reddy’s Laboratories: The USFDA has issued a Voluntary Action Indicated (VAI) status for Dr. Reddy’s Srikakulam plant, closing the inspection with no significant observations.Torrent Pharmaceuticals: Received CCI approval for its ₹19,500 crore acquisition of JB Chemicals &amp; Pharmaceuticals, with minor voluntary modifications.Tata Motors: Delivered over one lakh passenger vehicles during the 30-day festive period, marking a 33% YoY rise, driven by strong SUV and EV demand.Ola Electric: Karnataka High Court grants temporary protection to CEO Bhavish Aggarwal and a senior executive amid an ongoing probe into an engineer’s death, which the company denies involvement in.Kirloskar Ferrous Industries: Bagged a ₹358 crore contract from ONGC for the supply of EUE tubing, pup joints, and crossovers, expanding its presence in the energy sector.HCL Technologies: Partnered with Dubai Islamic Bank to drive AI adoption across the bank’s ecosystem and strengthen its global digital transformation footprint.NMDC: Revised iron ore prices effective October 22, with Baila Lump set at ₹5,550 per tonne and Baila Fines at ₹4,750 per tonne.Lloyds Metals and Energy: Completed the acquisition of a 49.99% stake in Thriveni Pellets and allotted ₹285.88 crore worth of shares to Adler Industrial Services.Fusion Finance: Secured IRDAI’s Corporate Agent (Composite) license, enabling it to offer insurance products alongside financial services.Zaggle Prepaid Ocean Services: Signed a five-year deal with Megha City Gas Distribution to provide its Zaggle Fleet Program for efficient expense management.Nectar Lifesciences: Fully repaid secured debt of ₹1,338.35 crore, leading to the release of all consortium charges on company assets.Rubicon Research: Subsidiary Advagen Holdings will invest up to $3 million in Gen1E Lifesciences through a Series Prime Preferred Stock acquisition.United Breweries: Heineken reported mid-single-digit revenue growth in India despite volume declines due to heavy monsoons, with premium brands like Kingfisher Ultra Max driving gains.Filatex India: Signed an MoU with Revti Business and Wastewear to collaborate on textile waste recycling, product innovation, and global co-branding.Gulshan Polyols: Received ethanol supply orders worth ₹1,184.86 crore from oil marketing companies for ESY 2025–26.LTIMindtree: President &amp; Whole-time Director Nachiket Deshpande has resigned, effective October 31.Bharti Airtel: Shivan Bhargava, Director – Customer Experience, has resigned and will transition out of the company within 3, 4 months.Quarterly Earnings HighlightsJain Resource Recycling: Q2 consolidated profit surged 77.7% YoY to ₹99.2 crore from ₹55.8 crore, while revenue rose 51.8% to ₹2,113.7 crore. The company also signed a joint venture with C&amp;Y Group Investments to set up a recycling and manufacturing facility in Gujarat.Epack Prefab Technologies: The company reported a 104.2% YoY jump in profit to ₹29.5 crore, with revenue up 61.9% to ₹433.9 crore, reflecting strong execution and demand momentum.Q2 Results TodayHindustan Unilever, Colgate Palmolive (India), Laurus Labs, PTC India Financial Services, Tata Teleservices (Maharashtra), Fabtech Technologies, Jumbo Bag, Andhra Cements, Sagar Cements, South India Paper Mills, and Vardhman Textiles.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	11.90	--	--	N/A
Q2 '26	9.21	11.10	20.56%	BEAT
Q1 '26	8.75	5.33	-39.06%	MISSED
Q4 '25	10.16	2.64	-74.01%	MISSED
Q3 '25	13.93	14.52	4.21%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

DRREDDY.NSE Earnings

Latest Earnings Results: Q2 '26

Historical Earnings